GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MARX Biotech Co 7731.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

4.09

+1.49%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 635.9m

FY2021FY2025

Net income

TWD 42.9m

FY2021FY2025

Free cash flow

−TWD 162.8m

FY2021FY2025

Shareholders' equity

TWD 359.4m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueTWD 635.9mTWD 618.2mTWD 289.9mTWD 110.6mTWD 97.6m
Gross profitTWD 394.6mTWD 430.1mTWD 214.6mTWD 84.2mTWD 74.8m
Research and developmentTWD 315,000TWD 26.0mTWD 597,000——
Operating income−TWD 139.5m−TWD 77.4m−TWD 14.3mTWD 898,000TWD 15.1m
Net incomeTWD 42.9m−TWD 96.8m−TWD 12.9mTWD 2.8mTWD 13.8m
Diluted earnings per share0.08-0.18-0.030.010.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsTWD 832.7mTWD 731.2mTWD 394.8mTWD 103.2mTWD 91.1m
Cash and short-term investments—TWD 78.2mTWD 152.8mTWD 27.7mTWD 16.1m
Total liabilitiesTWD 473.3mTWD 479.9mTWD 101.9mTWD 42.5mTWD 25.5m
DebtTWD 164.2mTWD 277.4mTWD 1.9mTWD 13.8mTWD 2.1m
Shareholders' equityTWD 359.4mTWD 251.2mTWD 293.0mTWD 60.7mTWD 65.6m
Shares outstanding506m524m498m506m506m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−TWD 148.7m−TWD 107.2m−TWD 14.1mTWD 11.4m−TWD 16.7m
Capital spending−TWD 14.1m−TWD 218.6m−TWD 1.7m−TWD 696,000−TWD 47,000
Free cash flow−TWD 162.8m−TWD 325.7m−TWD 15.9mTWD 10.7m−TWD 16.8m
Dividends paid——−TWD 6.6m−TWD 7.3m—

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Jun 2023
RevenueTWD 154.5mTWD 154.5mTWD 404.0mTWD 202.0mTWD 214.3mTWD 107.1mTWD 229.9mTWD 60.0m
Gross profitTWD 108.1mTWD 108.1mTWD 269.4mTWD 134.7mTWD 157.8mTWD 80.3mTWD 167.0mTWD 47.6m
Operating income−TWD 35.0m−TWD 17.5mTWD 269.4m−TWD 19.3m−TWD 46.5m−TWD 23.2m−TWD 19.3mTWD 2.4m
Net income−TWD 19.0m−TWD 19.0m−TWD 45.0m−TWD 22.5m−TWD 51.8m−TWD 25.9m−TWD 14.9mTWD 1.9m
Diluted earnings per share-0.04-0.04-0.09-0.04-0.10-0.05-0.030.00
Cash from operations−TWD 87.0m−TWD 43.0m−TWD 58.0m−TWD 29.0m−TWD 48.0m−TWD 24.0m−TWD 18.0mTWD 4.0m
Capital spending−TWD 3.0m−TWD 3.0m−TWD 101.0m−TWD 101.0m−TWD 2.0m−TWD 1.0m——
Free cash flow−TWD 90.0m−TWD 46.0m−TWD 159.0m−TWD 130.0m−TWD 50.0m−TWD 25.0m——
Total assetsTWD 733.0mTWD 733.0mTWD 731.2mTWD 731.2mTWD 413.5mTWD 413.5mTWD 394.8mTWD 198.7m
Cash and short-term investmentsTWD 27.5mTWD 27.5mTWD 78.2mTWD 78.2mTWD 98.0mTWD 98.0mTWD 152.8mTWD 124.4m
DebtTWD 369.2mTWD 197.5mTWD 272.3mTWD 107.2mTWD 10.9mTWD 5.4mTWD 2.5mTWD 11.6m
Shareholders' equityTWD 213.8mTWD 213.8mTWD 251.2mTWD 251.2mTWD 246.2mTWD 246.2mTWD 293.0mTWD 150.1m

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin62.1%69.6%74.0%76.1%76.6%
Operating margin11.2%-15.4%-5.2%4.5%18.1%
Net margin6.8%-15.7%-4.5%2.6%14.1%
Return on equity11.9%-38.5%-4.4%4.7%21.0%
Return on assets5.2%-13.2%-3.3%2.7%15.1%
Free cash flow yield-6.5%5.2%-0.6%——
Revenue growth2.9%113.2%162.0%13.4%—
Earnings growth-144.3%649.6%-556.3%-79.5%—
Current ratio1.78x1.34x3.40x2.31x3.59x
Debt to equity0.46x1.08x0.01x0.21x0.02x
Equity ratio43.2%34.4%74.2%58.9%72.0%
Interest coverage5.22x-43.09x-40.63x44.04x361.10x
R&D as a share of sales0.0%4.2%0.2%——
Buybacks as a share of market value3.4%-5.2%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue77.9%——
Net income147.5%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin65.8%67.9%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings56.2-37.6
Price to sales3.95.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 22 Jul 2024
  • 2-for-1 split · 11 Jul 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.